medigraphic.com
ISSN 1561-3119 (Electronic)

2020, Number 1

<< Back Next >>

Rev Cubana Pediatr 2020; 92 (1)

Care to the neonates exposed or infected with the varicella-zoster virus

Roig ÁT

Language: Spanish
References: 19
Page: 1-11
PDF size: 271.48 Kb.


ABSTRACT

The pregnant woman with varicella in the first quarter of pregnancy can transmit the infection to the fetus, in which case there is a risk of miscarriage or fetal death or permanent sequelae in the product of the gestation. The aim of this communication is to upgrade perinatologists, neonatologists and epidemiologists in the management of the neonate exposed or infected by the varicella-zoster virus in the national context. The infection by the virus in the neonatal period can be serious and fatal in extremely premature neonates, in preterm children of mothers without previous exposure to the virus and in newborns whose mothers have showned exanthem five days before delivery or up to two days after this. Varicella is preventable by vaccination and in developed countries there is a specific gammaglobulin against the varicella-zoster virus to be applied in patients exposed to this virus with high risk of presenting severe forms of the disease. In the national context, the infection by the varicella virus is frequent and active and passive immunization is not available, so it is necessary to be updated in the handling of vulnerable groups to this infection.


REFERENCES

  1. Gardella C, Brown Z. Managing varicella zoster infection in pregnancy. Clev Clin J Med. 2007;74(4):290-6.

  2. Comité Asesor de Vacunas (CAV-AEP). Varicela. Manual de vacunas en línea de la AEP. Madrid: AEP; 2018. [acceso 30/12/2018]. Disponible en: http://vacunasaep.org/documentos/manual/cap-41

  3. Centers for Disease Control and Prevention. Varicella. In: CDC, editor. Epidemiology and Prevention of Vaccine Preventable Diseases (The Pink Book), 13th ed. Atlanta: CDC; 2019 [acceso 04/03/2019]. Disponible en: http://www.cdc.gov/vaccines/pubs/pinkbook/varicella.html

  4. Centers for Disease Control and Prevention (CDC). Chickenpox for healthcare professionals. Atlanta: CDC ; 2019 [acceso 31/12/2019]. Disponible en: http://www.cdc.gov/chickenpox/index.htlm

  5. Kempf W, Meylan P, Gerber S, Aebi C, Agosti R, Büchner S, et al. Swiss recommendations for the management of varicella zoster virus infections. Swiss Med Wkly. 2007;137:239-51.

  6. Acosta Herrera B. Herpesvirus. En: Llop Hernández A, Valdés-Dapena Vovanco MM, Zuazo Silva JL, ediotres. Microbiología y Parasitología Médicas. La Habana: Editorial Ciencias Médicas; 2001. p. 109-41.

  7. Sauerbrei A, Wutzler P. Herpes simplex and varicella-zoster virus infections during pregnancy: current concepts of prevention, diagnosis and therapy. Part 2: Varicella-zoster virus infections. Med Microbiol Immunol. 2007;196:95-102.

  8. De Paschale M, Cleric P. Microbiology laboratory and the management of mother-child varicella-zoster virus infection. World J Virol. 2016;5(3):97-214.

  9. Romero García A, Albañil Ballesteros MR. Grupo de Patología Infecciosa de laAsociación Española de Pediatría de Atención Pimaria (AEPap). Varicela Congénita y Neonatal. Madrid: AEPap; 2015 [acceso 04/03/2019]. Disponible en: http://www.aepap.org/grupos/grupo-de-patologiainfecciosa/documentos-del-gpi

  10. American Academy of Pediatrics. Varicela-Zoster Infections In: Kimberlin DW, BradyMT, Jackson MA, Long SS, editors. Red Book: 2015 Report of the Committee on InfectiousDiseases. 30th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2015. p.846-60.

  11. Siegel JD, Rhinehart E, Jackson M, Chiarello L. Healthcare Infection Control PracticesAdvisory Committee. Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings. 2007 [acceso 04/03/2019]. Disponible en : https://www.cdc.gov/infectioncontrol/guidelines/isolation/index.html

  12. Sola A, Piasek CZ. Neofarma. Fármacos en Neonatología SIBEN. México: IntersistemasSA de CV; 2014.

  13. Kett JC. Perinatal Varicella. Pediatric in Rev. 2013 [acceso 09/06/2018];34(1);49-51.Disponible en: http://pedsinreview.aappublications.org/content/34/1/49

  14. Petersen R, Miller AS. Varicella Zoster Virus Infection in Neonates. NeoRev. 2016[acceso 09/06/2018];17(9):e508. Disponible en : http://neoreviews.aappublications.org/content/17/9/e507

  15. Schleiss MR. Marsh K J. Viral infections of the fetus and newborn. In: Gleason CA, JuulSE, editors. Avery's disease of the newborn.. 10 th ed. Elsiever: Philadelphia: Elsiever; 2018. p. 482-526.

  16. Gershon AA, Marin M, Seward JF. Varicella, Measles and Mumps. In: Wilson CB,Nizet V, Maldonado YA, Remington JS, Klein JO, editors. Remington and Kleins's. Infectious Diseases of de Fetus and Newborn Infant. 8th ed. Philadelphia: Elsevier; 2016. p. 675-723.

  17. Blumental S, Lepage P. Management of varicella in neonates and infants. BMJPaediatrics Open. 2019 [acceso 02/10/2019];3:e000433. Disponible en: https://bmjpaedsopen.bmj.com/content/bmjpo/3/1/e000433.full.pdf

  18. Royal College of Obstetricians & Gynaecologists. Chickenpox in Pregnancy. 2015[acceso 09/06/2018]. Disponible en: https://www.rcog.org.uk/globalassets/documents/guidelines/gtg_13.pdf

  19. Centers for Disease Control and Prevention (CDC). Updated Recommendations for Useof VariZIG - United States, 2013. MMWR. 2013;62(28):574-6.




2020     |     www.medigraphic.com